Home
>
National Drug Code (NDC)
>
Ciclopirox
Ciclopirox - 68462-455-35 - (Ciclopirox)
Drug Information of Ciclopirox
| Product NDC: | 68462-455 |
| Proprietary Name: | Ciclopirox |
| Non Proprietary Name: | Ciclopirox |
| Active Ingredient(s): | 7.7 mg/g & nbsp; Ciclopirox |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ciclopirox
| Product NDC: | 68462-455 |
| Labeler Name: | Glenmark Generics |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091595 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120229 |
Package Information of Ciclopirox
| Package NDC: | 68462-455-35 |
| Package Description: | 30 g in 1 TUBE (68462-455-35) |
NDC Information of Ciclopirox
| NDC Code | 68462-455-35 |
| Proprietary Name | Ciclopirox |
| Package Description | 30 g in 1 TUBE (68462-455-35) |
| Product NDC | 68462-455 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ciclopirox |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20120229 |
| Marketing Category Name | ANDA |
| Labeler Name | Glenmark Generics |
| Substance Name | CICLOPIROX |
| Strength Number | 7.7 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
